{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:49:14Z","timestamp":1790293754784,"version":"4.1.0"},"reference-count":127,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ejim.2018.10.014","type":"journal-article","created":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T10:45:08Z","timestamp":1540205108000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Extrahepatic autoimmunity in autoimmune liver disease"],"prefix":"10.1016","volume":"59","author":[{"given":"Annarosa","family":"Floreani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6398-8237","authenticated-orcid":false,"given":"Sara","family":"De Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Francesca","family":"Secchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6937-8664","authenticated-orcid":false,"given":"Nora","family":"Cazzagon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2018.10.014_bb0005","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11684-015-0386-y","article-title":"Autoimmune hepatitis","volume":"9","author":"Sahebjam","year":"2015","journal-title":"Front Med"},{"key":"10.1016\/j.ejim.2018.10.014_bb0010","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0140-6736(12)62163-1","article-title":"Autoimmune hepatitis","volume":"382","author":"Heneghan","year":"2013","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ejim.2018.10.014_bb0015","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1089-3261(02)00007-7","article-title":"Autoimmune hepatitis and overlap syndromes","volume":"6","author":"Dienes","year":"2002","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.ejim.2018.10.014_bb0020","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1586\/17474124.1.2.329","article-title":"Overlap syndromes with autoimmune hepatitis in chronic cholestatic liver diseases","volume":"1","author":"Silveira","year":"2007","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0025","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.3748\/wjg.14.3368","article-title":"Overlap syndromes among autoimmune liver diseases","volume":"14","author":"Rust","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0030","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/s-2005-916322","article-title":"Overlap syndromes","volume":"25","author":"Beuers","year":"2005","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.ejim.2018.10.014_bb0035","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/MCG.0b013e3181c74e0d","article-title":"Concurrent autoimmune diseases in patients with autoimmune hepatitis","volume":"44","author":"Teufel","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0040","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1097\/MEG.0000000000000424","article-title":"Autoimmune liver disease and concomitant extrahepatic autoimmune disease","volume":"27","author":"Muratori","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0045","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology (Baltimore, MD)"},{"key":"10.1016\/j.ejim.2018.10.014_bb0050","doi-asserted-by":"crossref","first-page":"2376231","DOI":"10.1155\/2017\/2376231","article-title":"Extrahepatic autoimmune diseases in patients with autoimmune liver diseases: A phenomenon neglected by gastroenterologists","volume":"2017","author":"Guo","year":"2017","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.ejim.2018.10.014_bb0055","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/MEG.0b013e328350f95b","article-title":"Autoimmune hepatitis\/primary biliary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases","volume":"24","author":"Efe","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0060","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/liv.13236","article-title":"Concurrent extrahepatic autoimmunity in autoimmune hepatitis: implications for diagnosis, clinical course and long-term outcomes","volume":"37","author":"Wong","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.ejim.2018.10.014_bb0065","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/s00535-011-0421-y","article-title":"Present status of autoimmune hepatitis in Japan: a nationwide survey","volume":"46","author":"Abe","year":"2011","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0070","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s12016-017-8649-9","article-title":"Skin manifestations associated with autoimmune liver diseases: a systematic review","volume":"53","author":"Terziroli Beretta-Piccoli","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0075","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/liv.12028","article-title":"Non-IBD immunological diseases are a risk factor for reduced survival in PSC","volume":"33","author":"Rupp","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.ejim.2018.10.014_bb0080","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2013.06.016","article-title":"The interplay between regulatory and effector T cells in autoimmune hepatitis: Implications for innovative treatment strategies","volume":"46","author":"Muratori","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.ejim.2018.10.014_bb0085","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.3389\/fimmu.2018.01682","article-title":"The IL-17 family of cytokines in psoriasis: IL-17A and beyond","volume":"9","author":"Brembilla","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0090","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.jid.2016.02.812","article-title":"Increased risk of autoimmune hepatitis in patients with psoriasis: a Danish nationwide cohort study","volume":"136","author":"Jensen","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0095","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1111\/j.1440-1746.2007.05048.x","article-title":"Spectrum of autoimmune liver diseases in western India","volume":"22","author":"Amarapurkar","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0100","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MCG.0b013e31802dbdfc","article-title":"Frequency of concurrent autoimmune disorders in patients with autoimmune hepatitis: effect of age, gender, and genetic background","volume":"42","author":"Bittencourt","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0105","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/BOR.0b013e328010c56b","article-title":"Autoimmune liver disease and rheumatic manifestations","volume":"19","author":"Czaja","year":"2007","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0110","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.rdc.2017.09.008","article-title":"Rheumatic manifestations in autoimmune liver disease","volume":"44","author":"Selmi","year":"2018","journal-title":"Rheum Dis Clin North Am"},{"issue":"Suppl. 2","key":"10.1016\/j.ejim.2018.10.014_bb0115","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000440707","article-title":"Association of extrahepatic manifestations with autoimmune hepatitis","volume":"33","author":"Wong","year":"2015","journal-title":"Digest Dis (Basel, Switzerland)"},{"key":"10.1016\/j.ejim.2018.10.014_bb0120","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s13317-017-0098-1","article-title":"Personalized medicine in rheumatology: the paradigm of serum autoantibodies","volume":"8","author":"Sirotti","year":"2017","journal-title":"Autoimmunity Highlights"},{"key":"10.1016\/j.ejim.2018.10.014_bb0125","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/S0140-6736(10)61965-4","article-title":"Primary biliary cirrhosis","volume":"377","author":"Selmi","year":"2011","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ejim.2018.10.014_bb0130","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrgastro.2015.136","article-title":"Coeliac disease and autoimmune disease-genetic overlap and screening","volume":"12","author":"Lundin","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/gutjnl-2011-301346","article-title":"The Oslo definitions for coeliac disease and related terms","volume":"62","author":"Ludvigsson","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2018.10.014_bb0140","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1136\/gutjnl-2013-306578","article-title":"Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology","volume":"63","author":"Ludvigsson","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2018.10.014_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2005.08.044","article-title":"Trends in the presentation of celiac disease","volume":"119","author":"Rampertab","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.ejim.2018.10.014_bb0150","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s12016-008-8086-x","article-title":"Pathogenesis and clinical significance of liver injury in celiac disease","volume":"36","author":"Volta","year":"2009","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0155","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2036.2011.04685.x","article-title":"Meta-analysis: coeliac disease and hypertransaminasaemia","volume":"34","author":"Sainsbury","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2018.10.014_bb0160","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jaut.2013.06.013","article-title":"Mucosal immunity in liver autoimmunity: a comprehensive review","volume":"46","author":"Trivedi","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.ejim.2018.10.014_bb0165","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1023\/A:1020166605016","article-title":"Genetic bases of autoimmune hepatitis","volume":"47","author":"Czaja","year":"2002","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ejim.2018.10.014_bb0170","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1128\/CMR.00106-13","article-title":"Gouveia Peluzio Mdo C. Intestinal microbiota and probiotics in celiac disease","volume":"27","author":"de Sousa Moraes","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ejim.2018.10.014_bb0175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/apt.12794","article-title":"Systematic review: The epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease","volume":"40","author":"Gizard","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2018.10.014_bb0180","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/j.1572-0241.2005.41841.x","article-title":"Clinical course and outcome of autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome","volume":"100","author":"Floreani","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0185","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/liv.13265","article-title":"Hepatic manifestations of inflammatory bowel diseases","volume":"37","author":"Restellini","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.ejim.2018.10.014_bb0190","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/ibd.22864","article-title":"Pediatric ulcerative colitis associated with autoimmune diseases: a distinct form of inflammatory bowel disease?","volume":"18","author":"Ordonez","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.ejim.2018.10.014_bb0195","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/MPG.0000000000001759","article-title":"Anti-TNFalpha treatment in children and adolescents with combined inflammatory bowel disease and autoimmune liver disease","volume":"66","author":"Nedelkopoulou","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.ejim.2018.10.014_bb0200","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0168-8278(92)90178-R","article-title":"Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis","volume":"14","author":"Perdigoto","year":"1992","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0205","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.3748\/wjg.v20.i17.4846","article-title":"Inflammatory bowel disease and celiac disease: overlaps and differences","volume":"20","author":"Pascual","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0210","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000445133","article-title":"The role of T-cell subsets in chronic inflammation in celiac disease and inflammatory bowel disease patients: more common mechanisms or more differences?","volume":"1","author":"Hisamatsu","year":"2016","journal-title":"Inflammatory Intest Dis"},{"key":"10.1016\/j.ejim.2018.10.014_bb0215","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s12016-014-8427-x","article-title":"Extrahepatic autoimmune conditions associated with primary biliary cirrhosis","volume":"48","author":"Floreani","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0220","first-page":"258","article-title":"Pulmonary manifestations among patients with primary biliary cirrhosis","volume":"4","author":"Koksal","year":"2016","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0225","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1136\/bmj.4.5731.340","article-title":"\u201cSicca complex\u201d in liver disease","volume":"4","author":"Golding","year":"1970","journal-title":"Br Med J"},{"key":"10.1016\/j.ejim.2018.10.014_bb0230","doi-asserted-by":"crossref","first-page":"31","DOI":"10.7326\/0003-4819-79-1-31","article-title":"Features of Sjogren's syndrome in primary biliary cirrhosis","volume":"79","author":"Alarcon-Segovia","year":"1973","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2018.10.014_bb0235","first-page":"365","article-title":"Autoimmune associations in primary biliary cirrhosis","volume":"57","author":"Culp","year":"1982","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ejim.2018.10.014_bb0240","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hep.1840110504","article-title":"Sjogren's syndrome in patients with primary biliary cirrhosis","volume":"11","author":"Tsianos","year":"1990","journal-title":"Hepatology (Baltimore, MD)"},{"key":"10.1016\/j.ejim.2018.10.014_bb0245","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1365-2796.1991.tb00470.x","article-title":"Features of Sjogren's syndrome in patients with primary biliary cirrhosis","volume":"230","author":"Uddenfeldt","year":"1991","journal-title":"J Intern Med"},{"key":"10.1016\/j.ejim.2018.10.014_bb0250","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/PL00009532","article-title":"Primary biliary cirrhosis, sicca complex, and dysphagia","volume":"12","author":"Mang","year":"1997","journal-title":"Dysphagia"},{"key":"10.1016\/j.ejim.2018.10.014_bb0255","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1136\/ard.60.11.1046","article-title":"Rheumatic disorders and primary biliary cirrhosis: an appraisal of 170 Italian patients","volume":"60","author":"Marasini","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2018.10.014_bb0260","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s40744-017-0074-2","article-title":"Chronic autoimmune epithelitis in Sjogren's syndrome and primary biliary cholangitis: a comprehensive review","volume":"4","author":"Selmi","year":"2017","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.ejim.2018.10.014_bb0265","article-title":"Increased risks of spontaneous bacterial peritonitis and interstitial lung disease in primary biliary cirrhosis patients with concomitant Sjogren syndrome","volume":"95","author":"Chen","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.ejim.2018.10.014_bb0270","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.20907","article-title":"Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients","volume":"42","author":"Gershwin","year":"2005","journal-title":"Hepatology (Baltimore, MD)"},{"key":"10.1016\/j.ejim.2018.10.014_bb0275","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.3748\/wjg.v19.i31.5131","article-title":"Connective tissue diseases in primary biliary cirrhosis: a population-based cohort study","volume":"19","author":"Wang","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0280","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3899\/jrheum.160243","article-title":"Prevalence of systemic sclerosis in primary biliary cholangitis using the new ACR\/EULAR classification criteria","volume":"44","author":"Zheng","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0285","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.semarthrit.2017.10.004","article-title":"Hepatobiliary involvement in systemic sclerosis and the cutaneous subsets: characteristics and survival of patients from the Spanish RESCLE Registry","volume":"47","author":"Mari-Alfonso","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ejim.2018.10.014_bb0290","doi-asserted-by":"crossref","first-page":"892","DOI":"10.3109\/s10165-012-0607-z","article-title":"High prevalence of primary biliary cirrhosis and disease-associated autoantibodies in Japanese patients with systemic sclerosis","volume":"22","author":"Imura-Kumada","year":"2012","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0295","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1055\/s-0034-1383734","article-title":"Primary biliary cirrhosis: overlaps with other autoimmune disorders","volume":"34","author":"Floreani","year":"2014","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.ejim.2018.10.014_bb0300","doi-asserted-by":"crossref","first-page":"713728","DOI":"10.1155\/2015\/713728","article-title":"Clinical characteristics of concomitant systemic lupus erythematosus and primary biliary cirrhosis: a literature review","volume":"2015","author":"Shizuma","year":"2015","journal-title":"J Immunol Res"},{"key":"10.1016\/j.ejim.2018.10.014_bb0305","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/BF01311724","article-title":"Increased incidence of hypothyroidism in primary biliary cirrhosis","volume":"28","author":"Elta","year":"1983","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ejim.2018.10.014_bb0310","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0016-5085(19)30497-4","article-title":"Primary biliary cirrhosis: the prevalence of hypothyroidism and its relationship to thyroid autoantibodies and sicca syndrome","volume":"78","author":"Crowe","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2018.10.014_bb0315","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1600-0676.1995.tb00110.x","article-title":"Prediction of prognosis of primary biliary cirrhosis in Japan","volume":"15","author":"Inoue","year":"1995","journal-title":"Liver"},{"key":"10.1016\/j.ejim.2018.10.014_bb0320","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1478-3231.2009.02003.x","article-title":"Thyroid dysfunction in primary biliary cirrhosis, primary sclerosing cholangitis and non-alcoholic fatty liver disease","volume":"29","author":"Silveira","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.ejim.2018.10.014_bb0325","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1471-230X-12-110","article-title":"Primary biliary cirrhosis in a genetically homogeneous population: disease associations and familial occurrence rates","volume":"12","author":"Mantaka","year":"2012","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0330","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/ajg.2016.479","article-title":"Thyroid dysfunction in primary biliary cholangitis: a comparative study at two European centers","volume":"112","author":"Floreani","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0335","doi-asserted-by":"crossref","first-page":"245","DOI":"10.15403\/jgld.2014.1121.263.kus","article-title":"Genetic risk factors for autoimmune thyroid disease might affect the susceptibility to and modulate the progression of primary biliary cholangitis","volume":"26","author":"Kus","year":"2017","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1016\/j.ejim.2018.10.014_bb0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/jaut.1997.0170","article-title":"Combined analysis of GAD65 and ICA512(IA-2) autoantibodies in organ and non-organ-specific autoimmune diseases confers high specificity for insulin-dependent diabetes mellitus","volume":"11","author":"Pietropaolo","year":"1998","journal-title":"J Autoimmun"},{"key":"10.1016\/j.ejim.2018.10.014_bb0345","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1007\/s00125-009-1427-3","article-title":"Familial association between type 1 diabetes and other autoimmune and related diseases","volume":"52","author":"Hemminki","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejim.2018.10.014_bb0350","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2169\/internalmedicine.51.6477","article-title":"Slowly progressive insulin-dependent diabetes in a patient with primary biliary cirrhosis with portal hypertension-type progression","volume":"51","author":"Takeshita","year":"2012","journal-title":"Internal Med (Tokyo, Japan)"},{"key":"10.1016\/j.ejim.2018.10.014_bb0355","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0140-6736(78)90480-4","article-title":"Primary biliary cirrhosis and coeliac disease: an association?","volume":"1","author":"Logan","year":"1978","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ejim.2018.10.014_bb0360","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1002\/hep.21949","article-title":"The liver in celiac disease","volume":"46","author":"Rubio-Tapia","year":"2007","journal-title":"Hepatology (Baltimore, MD)"},{"key":"10.1016\/j.ejim.2018.10.014_bb0365","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/gut.42.1.120","article-title":"The association between primary biliary cirrhosis and coeliac disease: a study of relative prevalences","volume":"42","author":"Kingham","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2018.10.014_bb0370","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/gut.44.5.736","article-title":"Risk of primary biliary liver cirrhosis in patients with coeliac disease: Danish and Swedish cohort data","volume":"44","author":"Sorensen","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2018.10.014_bb0375","first-page":"1524","article-title":"Screening patients with celiac disease for primary biliary cirrhosis and vice versa","volume":"92","author":"Bardella","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0380","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1023\/B:DDAS.0000007875.72256.e8","article-title":"IgA and IgG tissue transglutaminase antibody prevalence and clinical significance in connective tissue diseases, inflammatory bowel disease, and primary biliary cirrhosis","volume":"48","author":"Bizzaro","year":"2003","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ejim.2018.10.014_bb0385","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3748\/wjg.v9.i4.878","article-title":"Primary biliary cirrhosis and ulcerative colitis: a case report and review of literature","volume":"9","author":"Xiao","year":"2003","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0390","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.2169\/internalmedicine.50.5919","article-title":"Ulcerative colitis complicated with primary biliary cirrhosis","volume":"50","author":"Tada","year":"2011","journal-title":"Internal Med (Tokyo, Japan)"},{"key":"10.1016\/j.ejim.2018.10.014_bb0395","first-page":"900","article-title":"Two cases of inflammatory bowel disease diagnosed in the course of primary biliary cirrhosis","volume":"107","author":"Arai","year":"2010","journal-title":"Jpn J Gastroenterol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0400","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-220824","article-title":"Increased cholestatic enzymes in two patients with long-term history of ulcerative colitis: consider primary biliary cholangitis not always primary sclerosing cholangitis","volume":"2017","author":"Polychronopoulou","year":"2017","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.ejim.2018.10.014_bb0405","first-page":"101","article-title":"Crohn's disease of the small bowel, complicated by primary biliary cirrhosis, Hashimoto thyroiditis, and Raynaud's phenomenon: favorable response of all disorders to adalimumab treatment","volume":"6","author":"Triantafillidis","year":"2013","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0410","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1007\/s10620-005-3057-z","article-title":"Development of primary biliary cirrhosis in a patient with Crohn's disease: a case report and review of the literature","volume":"50","author":"Jang","year":"2005","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ejim.2018.10.014_bb0415","first-page":"1977","article-title":"Primary biliary cirrhosis and inflammatory bowel disease","volume":"88","author":"Yoshida","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0420","doi-asserted-by":"crossref","first-page":"6137","DOI":"10.3748\/wjg.v23.i33.6137","article-title":"Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases","volume":"23","author":"Halling","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0425","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/jhg.2015.59","article-title":"Disease susceptibility genes shared by primary biliary cirrhosis and Crohn's disease in the Japanese population","volume":"60","author":"Aiba","year":"2015","journal-title":"J Hum Genet"},{"key":"10.1016\/j.ejim.2018.10.014_bb0430","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/thx.36.3.208","article-title":"Pulmonary involvement in primary biliary cirrhosis","volume":"36","author":"Rodriguez-Roisin","year":"1981","journal-title":"Thorax"},{"key":"10.1016\/j.ejim.2018.10.014_bb0435","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/hep.1840130615","article-title":"Primary biliary cirrhosis: relation between hepatic function and pulmonary function in patients who never smoked","volume":"13","author":"Krowka","year":"1991","journal-title":"Hepatology (Baltimore, MD)"},{"key":"10.1016\/j.ejim.2018.10.014_bb0440","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1600-0676.1995.tb00670.x","article-title":"Primary biliary cirrhosis: lung involvement","volume":"15","author":"Costa","year":"1995","journal-title":"Liver"},{"key":"10.1016\/j.ejim.2018.10.014_bb0445","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1378\/chest.90.6.842","article-title":"Primary biliary cirrhosis. Subclinical inflammatory alveolitis in patients with normal chest roentgenograms","volume":"90","author":"Wallaert","year":"1986","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2018.10.014_bb0450","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1183\/09031936.93.03101206","article-title":"Subclinical alveolitis in immunological systemic disorders. Transition between health and disease?","volume":"3","author":"Wallaert","year":"1990","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ejim.2018.10.014_bb0455","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s10067-008-0917-x","article-title":"Interstitial lung disease and Sjogren's syndrome in primary biliary cirrhosis: a causal or casual association?","volume":"27","author":"Liu","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0460","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/MCG.0b013e31818aa11e","article-title":"Primary biliary cirrhosis complicated with interstitial lung disease: a prospective study in 178 patients","volume":"43","author":"Shen","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0465","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(03)13808-1","article-title":"Primary biliary cirrhosis","volume":"362","author":"Talwalkar","year":"2003","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ejim.2018.10.014_bb0470","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/0002-9343(73)90258-1","article-title":"Multisystem involvement in chronic liver disease. Studies on the incidence and pathogenesis","volume":"55","author":"Golding","year":"1973","journal-title":"Am J Med"},{"key":"10.1016\/j.ejim.2018.10.014_bb0475","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1056\/NEJM197212212872507","article-title":"Primary biliary cirrhosis or sarcoidosis\u2014or both","volume":"287","author":"Stanley","year":"1972","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2018.10.014_bb0480","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJM198303103081011","article-title":"Sarcoidosis and primary biliary cirrhosis. Associated disorders?","volume":"308","author":"Maddrey","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2018.10.014_bb0485","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1056\/NEJM198303103081006","article-title":"Multiorgan granulomas and mitochondrial antibodies","volume":"308","author":"Fagan","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2018.10.014_bb0490","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJM199804303381809","article-title":"Weekly clinicopathological exercises. Case 14\u20131998. A 49-year-old woman with primary biliary cirrhosis, pulmonary opacities, and a pleural effusion","volume":"338","author":"Case records of the Massachusetts General Hospital","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2018.10.014_bb0495","first-page":"279","article-title":"Sarcoidosis and primary biliary cirrhosis association: report of a new case","volume":"18","author":"Aqodad","year":"2014","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.ejim.2018.10.014_bb0500","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1579-2129(11)70063-5","article-title":"A combination of two rare granulomatous diseases","volume":"47","author":"Fuentes","year":"2011","journal-title":"Arch Bronconeumol"},{"issue":"2010","key":"10.1016\/j.ejim.2018.10.014_bb0505","first-page":"1733","article-title":"Pulmonary necrotizing sarcoid granulomatosis in a patient with primary biliary cirrhosis","volume":"135","author":"Frechen","year":"1946","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.ejim.2018.10.014_bb0510","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.2169\/internalmedicine.49.3457","article-title":"Sarcoidosis in a patient with systemic sclerosis and primary biliary cirrhosis","volume":"49","author":"Sakamoto","year":"2010","journal-title":"Internal Med (Tokyo, Japan)"},{"key":"10.1016\/j.ejim.2018.10.014_bb0515","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/pgmj.2008.067769","article-title":"Immune-mediated and chronic inflammatory disease in people with sarcoidosis: disease associations in a large UK database","volume":"85","author":"Rajoriya","year":"2009","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ejim.2018.10.014_bb0520","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jhep.2010.02.019","article-title":"Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis","volume":"53","author":"Corpechot","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0525","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/gut.2009.184218","article-title":"Case-control studies of risk factors for primary biliary cirrhosis in two United Kingdom populations","volume":"59","author":"Prince","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2018.10.014_bb0530","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5009\/gnl16510","article-title":"Inflammatory Bowel disease and primary sclerosing cholangitis: a review of the phenotype and associated specific features","volume":"12","author":"Palmela","year":"2018","journal-title":"Gut Liver"},{"key":"10.1016\/j.ejim.2018.10.014_bb0535","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.livres.2017.12.002","article-title":"Primary sclerosing cholangitis: a review and update","volume":"1","author":"Tabibian","year":"2017","journal-title":"Liver Res"},{"key":"10.1016\/j.ejim.2018.10.014_bb0540","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0140-6736(13)60096-3","article-title":"Primary sclerosing cholangitis","volume":"382","author":"Hirschfield","year":"2013","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ejim.2018.10.014_bb0545","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrgastro.2016.154","article-title":"Genetics of primary sclerosing cholangitis and pathophysiological implications","volume":"14","author":"Jiang","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0550","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ng.3745","article-title":"Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease","volume":"49","author":"Ji","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.ejim.2018.10.014_bb0555","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis","volume":"152","author":"Weismuller","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2018.10.014_bb0560","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1053\/j.gastro.2016.06.021","article-title":"Prevalence of sclerosing cholangitis detected by magnetic resonance cholangiography in patients with long-term inflammatory Bowel disease","volume":"151","author":"Lunder","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2018.10.014_bb0565","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis - a comprehensive review","volume":"67","author":"Karlsen","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0570","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gut.2004.046615","article-title":"PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"54","author":"Loftus","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2018.10.014_bb0575","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1097\/MIB.0b013e3182802893","article-title":"Inflammatory bowel disease in primary sclerosing cholangitis: a robust yet changing relationship","volume":"19","author":"Sinakos","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.ejim.2018.10.014_bb0580","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/liv.13548","article-title":"Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977\u20132011","volume":"38","author":"Sorensen","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.ejim.2018.10.014_bb0585","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s00534-010-0319-8","article-title":"Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"18","author":"Sano","year":"2011","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.ejim.2018.10.014_bb0590","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/ibd.21699","article-title":"Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients","volume":"18","author":"Jorgensen","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.ejim.2018.10.014_bb0595","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1007\/s10620-013-2697-7","article-title":"The phenotypic expression of inflammatory bowel disease in patients with primary sclerosing cholangitis differs in the distribution of colitis","volume":"58","author":"Schaeffer","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ejim.2018.10.014_bb0600","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cgh.2017.07.023","article-title":"Patients with ulcerative colitis and primary sclerosing cholangitis frequently have subclinical inflammation in the proximal colon","volume":"16","author":"Krugliak Cleveland","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0605","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11894-018-0620-2","article-title":"The IBD and PSC phenotypes of PSC-IBD","volume":"20","author":"Ricciuto","year":"2018","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.ejim.2018.10.014_bb0610","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/00365521.2017.1421705","article-title":"Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic Multicentre Study","volume":"53","author":"Lindstrom","year":"2018","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0615","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2018.10.014_bb0620","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue","volume":"54","author":"Boberg","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0625","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1034\/j.1600-0641.2000.033004543.x","article-title":"High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis","volume":"33","author":"van Buuren","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0630","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0168-8278(00)80004-5","article-title":"Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system","volume":"33","author":"Kaya","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2018.10.014_bb0635","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2036.2008.03722.x","article-title":"Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival","volume":"28","author":"Al-Chalabi","year":"2008","journal-title":"Aliment Pharmacol Ther"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620518304072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620518304072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:27:58Z","timestamp":1760606878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620518304072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":127,"alternative-id":["S0953620518304072"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2018.10.014","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extrahepatic autoimmunity in autoimmune liver disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2018.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}